This inventor holds 1 USPTO granted patent and 6 published patent applications and 3 EPO patents. Top assignees: Irbm S.p.a., Istituto Nazionale Di Genetica Molecolare - Ingm, Ospedale San Raffaele S.r.l.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2025
Title: Romano Di Fabio: Innovator in Molecular Genetics
Introduction: Romano Di Fabio is an accomplished inventor based in Pomezia, Italy. He has made significant contributions to the field of molecular genetics, particularly in the development of compounds that target various viral infections and diseases. Although he currently holds no granted patents, his innovative work continues to pave the way for future advancements in medical treatments.
Latest Patent Applications: Romano Di Fabio's latest patent applications include two notable inventions. The first is focused on Flavivirus inhibitors, which are compounds that inhibit Flavivirus NS2B-NS3 proteases and prevent the replication of flavivirus in cells. These compounds are particularly useful in treating infections caused by viruses such as Dengue, West Nile, Zika, and Japan Encephalitis. The second application involves (S)-1-(5-((pyridin-3-yl)thio)pyrazin-2-yl)-4'H,6'H-spiro[piperidine-4,5'-pyrrolo[1,2-b]pyrazol]-4'-amine derivatives and similar compounds. This invention relates to SHP2 inhibitors for the treatment of various conditions, including cancer, cardiovascular diseases, and autoimmune disorders. The applications also detail pharmaceutical compositions containing these compounds and their methods of synthesis.
Conclusion: Romano Di Fabio is a dedicated inventor whose work in molecular genetics holds promise for future medical advancements. His innovative patent applications reflect his commitment to addressing significant health challenges through scientific research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile